- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25Q2 (20) | 103 | 0.0 | 1.98 | 5.96 | -56.01 | -44.61 | 10.23 | 212.42 | 174.26 | 19.50 | 43.91 | 9.43 | 48.68 | 8.66 | 10.21 | 41.48 | -1.66 | -6.87 | 20.39 | 34.06 | -0.59 | 13.05 | -58.51 | -48.86 | 9.93 | 45.81 | 9.6 | 6.17 | -55.9 | -43.13 | 11.41 | -83.06 | -68.65 | 13.05 | -58.51 | -48.86 | -6.69 | 36.05 | -63.22 |
| 25Q1 (19) | 103 | 0.98 | 1.98 | 13.55 | 128.11 | 91.65 | -9.10 | -338.85 | -249.92 | 13.55 | -64.98 | 91.65 | 44.8 | -22.03 | 56.81 | 42.18 | 29.11 | -19.96 | 15.21 | 64.61 | -51.28 | 31.45 | 187.21 | 20.87 | 6.81 | 28.25 | -23.65 | 13.99 | 131.62 | 95.39 | 67.36 | 420.96 | 95.7 | 31.45 | 187.21 | 20.87 | -14.86 | 33.86 | -199.12 |
| 24Q4 (18) | 102 | 0.0 | 2.0 | 5.94 | -60.4 | 5.32 | 3.81 | -59.38 | -61.59 | 38.69 | 17.71 | 28.11 | 57.46 | -7.69 | 79.23 | 32.67 | -13.82 | -38.28 | 9.24 | -45.42 | -73.92 | 10.95 | -55.76 | -39.8 | 5.31 | -49.62 | -53.26 | 6.04 | -60.6 | 6.71 | 12.93 | -50.35 | -39.01 | 10.95 | -55.76 | -39.8 | 16.62 | -10.50 | 46.05 |
| 24Q3 (17) | 102 | 0.99 | 0.99 | 15.00 | 39.41 | 106.04 | 9.38 | 151.47 | -6.11 | 32.87 | 84.46 | 33.46 | 62.25 | 40.93 | 102.44 | 37.91 | -14.89 | -29.09 | 16.93 | -17.45 | -57.29 | 24.75 | -3.02 | 2.19 | 10.54 | 16.34 | -13.54 | 15.33 | 41.29 | 109.14 | 26.04 | -28.44 | -13.23 | 24.75 | -3.02 | 2.19 | 47.77 | 45.80 | 56.46 |
| 24Q2 (16) | 101 | 0.0 | 31.17 | 10.76 | 52.19 | 20.22 | 3.73 | -38.55 | -62.32 | 17.82 | 152.05 | -20.94 | 44.17 | 54.6 | 40.71 | 44.54 | -15.48 | -18.94 | 20.51 | -34.3 | -52.2 | 25.52 | -1.92 | 14.29 | 9.06 | 1.57 | -32.74 | 10.85 | 51.54 | 56.79 | 36.39 | 5.72 | 12.07 | 25.52 | -1.92 | 14.29 | 21.86 | 38.77 | -38.68 |
| 24Q1 (15) | 101 | 1.0 | 32.89 | 7.07 | 25.35 | -48.09 | 6.07 | -38.81 | -45.36 | 7.07 | -76.59 | -48.09 | 28.57 | -10.89 | -40.24 | 52.70 | -0.43 | 30.83 | 31.22 | -11.88 | -3.55 | 26.02 | 43.05 | 19.25 | 8.92 | -21.48 | -42.34 | 7.16 | 26.5 | -31.09 | 34.42 | 62.36 | 14.09 | 26.02 | 43.05 | 19.25 | -3.32 | 1.41 | -19.76 |
| 23Q4 (14) | 100 | -0.99 | 33.33 | 5.64 | -22.53 | 5.03 | 9.92 | -0.7 | 63.16 | 30.20 | 22.61 | 63.07 | 32.06 | 4.26 | -39.49 | 52.93 | -0.99 | 156.57 | 35.43 | -10.62 | 185.27 | 18.19 | -24.9 | 136.23 | 11.36 | -6.81 | 72.64 | 5.66 | -22.78 | 40.1 | 21.20 | -29.36 | 157.59 | 18.19 | -24.9 | 136.23 | 1.11 | -20.59 | 0.11 |
| 23Q3 (13) | 101 | 31.17 | 34.67 | 7.28 | -18.66 | -3.96 | 9.99 | 0.91 | 139.57 | 24.63 | 9.27 | 87.3 | 30.75 | -2.04 | 12.89 | 53.46 | -2.71 | 61.46 | 39.64 | -7.62 | 67.82 | 24.22 | 8.46 | 14.9 | 12.19 | -9.5 | 89.58 | 7.33 | 5.92 | 28.82 | 30.01 | -7.58 | 4.53 | 24.22 | 8.46 | 14.9 | -18.19 | -26.48 | -4.99 |
| 23Q2 (12) | 77 | 1.32 | 13.24 | 8.95 | -34.29 | 154.26 | 9.90 | -10.89 | 324.89 | 22.54 | 65.49 | 267.7 | 31.39 | -34.34 | 131.66 | 54.95 | 36.42 | 40.93 | 42.91 | 32.56 | 57.35 | 22.33 | 2.34 | 26.02 | 13.47 | -12.93 | 265.04 | 6.92 | -33.4 | 188.33 | 32.47 | 7.62 | 19.2 | 22.33 | 2.34 | 26.02 | -22.05 | 59.67 | 35.92 |
| 23Q1 (11) | 76 | 1.33 | 11.76 | 13.62 | 153.63 | 419.85 | 11.11 | 82.73 | 542.2 | 13.62 | -26.46 | 419.85 | 47.81 | -9.76 | 328.02 | 40.28 | 95.25 | 15.55 | 32.37 | 160.63 | 43.74 | 21.82 | 183.38 | 36.03 | 15.47 | 135.11 | 513.89 | 10.39 | 157.18 | 480.45 | 30.17 | 266.59 | 33.2 | 21.82 | 183.38 | 36.03 | 42.36 | 62.23 | 64.27 |
| 22Q4 (10) | 75 | 0.0 | 10.29 | 5.37 | -29.16 | 160.68 | 6.08 | 45.8 | 334.29 | 18.52 | 40.84 | 67.75 | 52.98 | 94.49 | 360.7 | 20.63 | -37.69 | -36.72 | 12.42 | -47.42 | -23.33 | 7.70 | -63.47 | -36.78 | 6.58 | 2.33 | 253.76 | 4.04 | -29.0 | 188.57 | 8.23 | -71.33 | -48.11 | 7.70 | -63.47 | -36.78 | 97.76 | 43.09 | 62.38 |
| 22Q3 (9) | 75 | 10.29 | 10.29 | 7.58 | 115.34 | 275.25 | 4.17 | 78.97 | 187.59 | 13.15 | 114.52 | 45.95 | 27.24 | 101.03 | 129.1 | 33.11 | -15.08 | 10.62 | 23.62 | -13.38 | 29.5 | 21.08 | 18.96 | 82.04 | 6.43 | 74.25 | 196.31 | 5.69 | 137.08 | 312.32 | 28.71 | 5.4 | 65.76 | 21.08 | 18.96 | 82.04 | 61.17 | 74.84 | 56.83 |
| 22Q2 (8) | 68 | 0.0 | 25.93 | 3.52 | 34.35 | 38.58 | 2.33 | 34.68 | 61.81 | 6.13 | 133.97 | -29.7 | 13.55 | 21.31 | 13.48 | 38.99 | 11.85 | 37.1 | 27.27 | 21.09 | 68.65 | 17.72 | 10.47 | 53.82 | 3.69 | 46.43 | 91.19 | 2.4 | 34.08 | 73.91 | 27.24 | 20.26 | 77.92 | 17.72 | 10.47 | 53.82 | 9.22 | 30.77 | 29.12 |
| 22Q1 (7) | 68 | 0.0 | 25.93 | 2.62 | 27.18 | -57.61 | 1.73 | 23.57 | -46.11 | 2.62 | -76.27 | -57.61 | 11.17 | -2.87 | -18.29 | 34.86 | 6.93 | -20.77 | 22.52 | 39.01 | -31.55 | 16.04 | 31.69 | -34.42 | 2.52 | 35.48 | -44.0 | 1.79 | 27.86 | -46.41 | 22.65 | 42.81 | -31.63 | 16.04 | 31.69 | -34.42 | -3.08 | 14.58 | 10.06 |
| 21Q4 (6) | 68 | 0.0 | 25.93 | 2.06 | 1.98 | -74.57 | 1.40 | -3.45 | 218.18 | 11.04 | 22.53 | 2.6 | 11.5 | -3.28 | 72.16 | 32.60 | 8.92 | -25.07 | 16.20 | -11.18 | 113.44 | 12.18 | 5.18 | -81.32 | 1.86 | -14.29 | 264.71 | 1.4 | 1.45 | -67.82 | 15.86 | -8.43 | -75.96 | 12.18 | 5.18 | -81.32 | -1.85 | -9.24 | -1.38 |
| 21Q3 (5) | 68 | 25.93 | 61.9 | 2.02 | -20.47 | 51.88 | 1.45 | 0.69 | 126.56 | 9.01 | 3.33 | 159.65 | 11.89 | -0.42 | 199.5 | 29.93 | 5.24 | -21.91 | 18.24 | 12.8 | 0.05 | 11.58 | 0.52 | -16.69 | 2.17 | 12.44 | 201.39 | 1.38 | 0.0 | 150.91 | 17.32 | 13.13 | 12.91 | 11.58 | 0.52 | -16.69 | - | - | 0.00 |
| 21Q2 (4) | 54 | 0.0 | 0.0 | 2.54 | -58.9 | 0.0 | 1.44 | -55.14 | 0.0 | 8.72 | 41.1 | 0.0 | 11.94 | -12.66 | 0.0 | 28.44 | -35.36 | 0.0 | 16.17 | -50.85 | 0.0 | 11.52 | -52.9 | 0.0 | 1.93 | -57.11 | 0.0 | 1.38 | -58.68 | 0.0 | 15.31 | -53.79 | 0.0 | 11.52 | -52.9 | 0.0 | - | - | 0.00 |
| 21Q1 (3) | 54 | 0.0 | 0.0 | 6.18 | -23.7 | 0.0 | 3.21 | 629.55 | 0.0 | 6.18 | -42.57 | 0.0 | 13.67 | 104.64 | 0.0 | 44.00 | 1.13 | 0.0 | 32.90 | 333.47 | 0.0 | 24.46 | -62.49 | 0.0 | 4.5 | 782.35 | 0.0 | 3.34 | -23.22 | 0.0 | 33.13 | -49.78 | 0.0 | 24.46 | -62.49 | 0.0 | - | - | 0.00 |
| 20Q4 (2) | 54 | 28.57 | 0.0 | 8.10 | 509.02 | 0.0 | 0.44 | -31.25 | 0.0 | 10.76 | 210.09 | 0.0 | 6.68 | 68.26 | 0.0 | 43.51 | 13.51 | 0.0 | 7.59 | -58.37 | 0.0 | 65.21 | 369.14 | 0.0 | 0.51 | -29.17 | 0.0 | 4.35 | 690.91 | 0.0 | 65.97 | 330.05 | 0.0 | 65.21 | 369.14 | 0.0 | - | - | 0.00 |
| 20Q3 (1) | 42 | 0.0 | 0.0 | 1.33 | 0.0 | 0.0 | 0.64 | 0.0 | 0.0 | 3.47 | 0.0 | 0.0 | 3.97 | 0.0 | 0.0 | 38.33 | 0.0 | 0.0 | 18.23 | 0.0 | 0.0 | 13.90 | 0.0 | 0.0 | 0.72 | 0.0 | 0.0 | 0.55 | 0.0 | 0.0 | 15.34 | 0.0 | 0.0 | 13.90 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/7 | 17.98 | 8.92 | 4.47 | 118.04 | 22.89 | 49.57 | N/A | 停業單位營收累計為748,490千元 | ||
| 2025/6 | 16.5 | 9.42 | -2.72 | 100.07 | 26.9 | 51.76 | 0.62 | 停業單位營收累計為655,938千元 | ||
| 2025/5 | 15.08 | -25.23 | -10.65 | 83.56 | 35.03 | 49.92 | 0.65 | 美國馬里蘭廠營收納入合併(停業單位營收累計為570,110千元) | ||
| 2025/4 | 20.17 | 37.54 | 22.81 | 68.48 | 52.16 | 52.11 | 0.62 | USL營收及美國馬里蘭廠營收納入合併(停業單位營收累計為479,077千元) | ||
| 2025/3 | 14.67 | -15.08 | 94.87 | 48.3 | 69.04 | 48.3 | 0.85 | USL營收及美國馬里蘭廠營收納入合併 | ||
| 2025/2 | 17.27 | 5.54 | 96.32 | 33.64 | 59.8 | 53.49 | 0.77 | USL營收及美國馬里蘭廠營收納入合併 | ||
| 2025/1 | 16.37 | -17.58 | 33.58 | 16.37 | 33.58 | 53.05 | 0.77 | - | ||
| 2024/12 | 19.86 | 17.98 | 107.93 | 192.58 | 35.61 | 57.58 | 0.96 | 113年USL營收及美國馬里蘭廠營收納入合併 | ||
| 2024/11 | 16.83 | -19.44 | 49.38 | 172.72 | 30.4 | 57.96 | 0.95 | - | ||
| 2024/10 | 20.89 | 3.23 | 85.94 | 155.89 | 28.63 | 59.83 | 0.92 | 113.04起合併子公司USL營收及113.08.20收購Emergent BioSolutions旗下位於美國馬里蘭康登鎮無菌製劑廠營收納入合併 | ||
| 2024/9 | 20.24 | 8.22 | 99.24 | 135.0 | 22.78 | 56.15 | 0.97 | 113.04起合併子公司USL營收及113.08.20收購Emergent BioSolutions旗下位於美國馬里蘭康登鎮無菌製劑廠營收納入合併 | ||
| 2024/8 | 18.7 | 8.67 | 88.55 | 114.76 | 15.0 | 52.88 | 1.03 | 113.04起合併子公司USL營收及113.08.20收購Emergent BioSolutions旗下位於美國馬里蘭康登鎮無菌製劑廠營收納入合併 | ||
| 2024/7 | 17.21 | 1.42 | 61.14 | 96.06 | 6.88 | 51.06 | 1.06 | 113.04起合併子公司Upsher-Smith Laboratories營收 | ||
| 2024/6 | 16.97 | 0.5 | 48.48 | 78.85 | -0.43 | 50.27 | 0.99 | - | ||
| 2024/5 | 16.88 | 2.77 | 55.75 | 61.88 | -8.68 | 40.83 | 1.22 | 113.04起合併子公司Upsher-Smith Laboratories營收 | ||
| 2024/4 | 16.43 | 118.25 | 80.08 | 45.0 | -20.94 | 32.75 | 1.52 | 113.04起合併子公司Upsher-Smith Laboratories營收 | ||
| 2024/3 | 7.53 | -14.45 | -42.53 | 28.57 | -40.22 | 28.57 | 0.83 | - | ||
| 2024/2 | 8.8 | -28.18 | -44.14 | 21.05 | -39.35 | 30.55 | 0.78 | - | ||
| 2024/1 | 12.25 | 28.91 | -35.37 | 12.25 | -35.37 | 33.02 | 0.72 | - | ||
| 2023/12 | 9.5 | -15.64 | -43.4 | 141.95 | 35.26 | 32.01 | 0.67 | 12月單月減少原因:子公司安成藥業11204起調整產品架構 | ||
| 2023/11 | 11.27 | 0.26 | -32.47 | 132.45 | 50.25 | 32.66 | 0.66 | 11月單月減少原因:子公司安成藥業11204起調整產品架構 | ||
| 2023/10 | 11.24 | 10.57 | -42.81 | 121.19 | 69.54 | 31.32 | 0.69 | 10月單月減少原因:子公司安成藥業11204起調整產品架構 | ||
| 2023/9 | 10.16 | 2.45 | -43.69 | 109.95 | 111.6 | 30.76 | 0.75 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/8 | 9.92 | -7.12 | 111.3 | 99.79 | 195.42 | 32.02 | 0.72 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/7 | 10.68 | -6.54 | 143.91 | 89.87 | 209.0 | 32.94 | 0.7 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/6 | 11.43 | 5.42 | 185.0 | 79.19 | 220.54 | 31.38 | 0.63 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/5 | 10.84 | 18.82 | 115.98 | 67.76 | 227.42 | 33.06 | 0.6 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/4 | 9.12 | -30.35 | 103.02 | 56.93 | 263.09 | 37.97 | 0.52 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/3 | 13.1 | -16.86 | 220.88 | 47.81 | 327.88 | 47.81 | 0.38 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/2 | 15.75 | -16.89 | 376.92 | 34.71 | 389.47 | 51.37 | 0.35 | 111.09起合併子公司安成國際藥業營收 | ||
| 2023/1 | 18.96 | 13.74 | 400.41 | 18.96 | 400.41 | 52.31 | 0.34 | 111.09起合併子公司安成國際藥業營收 | ||
| 2022/12 | 16.67 | -0.11 | 358.18 | 104.82 | 113.91 | 53.0 | 0.37 | 111.09起合併子公司安成國際藥業營收 | ||
| 2022/11 | 16.68 | -15.09 | 341.72 | 88.15 | 94.05 | 54.38 | 0.36 | 111.09起合併子公司安成國際藥業營收 | ||
| 2022/10 | 19.65 | 8.87 | 381.52 | 71.48 | 71.62 | 42.39 | 0.46 | 111.09起合併子公司安成國際藥業營收 | ||
| 2022/9 | 18.05 | 284.53 | 308.65 | 51.83 | 37.95 | 27.12 | 0.86 | 111.09起合併子公司安成國際藥業營收 | ||
| 2022/8 | 4.69 | 7.21 | 15.94 | 33.78 | 1.88 | 13.08 | 1.78 | - | ||
| 2022/7 | 4.38 | 9.2 | 29.45 | 29.08 | -0.06 | 13.41 | 1.74 | - | ||
| 2022/6 | 4.01 | -20.1 | 9.44 | 24.71 | -3.94 | 13.52 | 0.78 | - | ||
| 2022/5 | 5.02 | 11.69 | 18.15 | 20.7 | -6.17 | 13.6 | 0.77 | - | ||
| 2022/4 | 4.49 | 9.72 | 8.5 | 15.68 | -11.97 | 11.89 | 0.89 | - | ||
| 2022/3 | 4.09 | 23.95 | -24.75 | 11.19 | -18.17 | 11.19 | 0.84 | - | ||
| 2022/2 | 3.3 | -12.8 | -16.46 | 7.09 | -13.83 | 10.73 | 0.88 | - | ||
| 2022/1 | 3.79 | 4.14 | -11.39 | 3.79 | -11.39 | 11.2 | 0.84 | - | ||
| 2021/12 | 3.64 | -3.7 | 1.97 | 49.06 | 174.08 | 11.5 | 0.8 | 109.12起合併加拿大子公司營收 | ||
| 2021/11 | 3.78 | -7.44 | 147.41 | 45.43 | 216.91 | 12.27 | 0.74 | 109.12起合併加拿大子公司營收 | ||
| 2021/10 | 4.08 | -7.6 | 174.24 | 41.65 | 225.19 | 12.55 | 0.73 | 109.12起合併加拿大子公司營收 | ||
| 2021/9 | 4.42 | 9.1 | 201.29 | 37.57 | 231.89 | 11.85 | 0.84 | 109.12起合併加拿大子公司營收 | ||
| 2021/8 | 4.05 | 19.7 | 206.44 | 33.15 | 236.44 | 11.09 | 0.9 | 109.12起合併加拿大子公司營收 | ||
| 2021/7 | 3.38 | -7.67 | 185.36 | 29.1 | 241.09 | 11.29 | 0.88 | 109.12起合併加拿大子公司營收 | ||
| 2021/6 | 3.66 | -13.74 | 182.52 | 25.72 | 250.08 | 12.05 | 0.81 | 109.12起合併加拿大子公司營收 | ||
| 2021/5 | 4.25 | 2.57 | 241.96 | 22.06 | 264.55 | 13.83 | 0.71 | 109.12起合併加拿大子公司營收 | ||
| 2021/4 | 4.14 | -23.9 | 282.33 | 17.81 | 270.37 | 13.54 | 0.72 | 109.12起合併加拿大子公司營收 | ||
| 2021/3 | 5.44 | 37.6 | 348.05 | 13.67 | 266.89 | 13.67 | 0.78 | 109.12起合併加拿大子公司營收 | ||
| 2021/2 | 3.95 | -7.5 | 235.69 | 8.23 | 227.64 | 11.8 | 0.9 | 109.12起合併加拿大子公司營收 | ||
| 2021/1 | 4.28 | 19.85 | 220.54 | 4.28 | 220.54 | 9.37 | 1.14 | 109.12起合併加拿大子公司營收 | ||
| 2020/12 | 3.57 | 133.63 | 146.69 | 17.9 | 17.05 | 6.58 | 1.65 | 109.12起合併加拿大子公司營收 | ||
| 2020/11 | 1.53 | 2.59 | 16.75 | 14.33 | 3.52 | 4.48 | 2.42 | - | ||
| 2020/10 | 1.49 | 1.5 | 28.52 | 12.81 | 2.14 | 4.28 | 2.54 | - | ||
| 2020/9 | 1.47 | 10.97 | 31.38 | 11.32 | -0.54 | 0.0 | N/A | - | ||
| 2020/8 | 1.32 | 11.46 | -22.1 | 9.85 | -4.01 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 (10) | 102 | 2.0 | 35.82 | 21.88 | 22.98 | -43.84 | 192.46 | 35.54 | 40.06 | -18.63 | 17.58 | -52.45 | 20.99 | -2.96 | 33.83 | -35.55 | 49.55 | 21.92 | 39.39 | 30.0 |
| 2023 (9) | 100 | 33.33 | 29.39 | 60.6 | 40.92 | 185.95 | 142.0 | 35.32 | 49.23 | 77.34 | 36.97 | 101.8 | 21.63 | 62.02 | 52.49 | 173.1 | 40.64 | 120.87 | 30.3 | 117.67 |
| 2022 (8) | 75 | 10.29 | 18.30 | 66.21 | 14.31 | 90.8 | 104.94 | 114.16 | 27.76 | -18.64 | 18.32 | -14.19 | 13.35 | -12.75 | 19.22 | 83.75 | 18.4 | 79.69 | 13.92 | 85.6 |
| 2021 (7) | 68 | 25.93 | 11.01 | 3.09 | 7.50 | 269.46 | 49.0 | 172.22 | 34.12 | -12.76 | 21.35 | 69.98 | 15.30 | -52.4 | 10.46 | 362.83 | 10.24 | 72.1 | 7.5 | 29.76 |
| 2020 (6) | 54 | 38.46 | 10.68 | 35.71 | 2.03 | -35.56 | 18.0 | 17.72 | 39.11 | -6.99 | 12.56 | -44.3 | 32.14 | 61.1 | 2.26 | -34.49 | 5.95 | 83.08 | 5.78 | 89.51 |
| 2019 (5) | 39 | 44.44 | 7.87 | -50.53 | 3.15 | 125.0 | 15.29 | 11.44 | 42.05 | 29.54 | 22.55 | 65.2 | 19.95 | -38.43 | 3.45 | 84.49 | 3.25 | -33.26 | 3.05 | -31.15 |
| 2018 (4) | 27 | 8.0 | 15.91 | 2741.07 | 1.40 | 833.33 | 13.72 | 283.24 | 32.46 | -7.81 | 13.65 | 162.5 | 32.40 | 655.24 | 1.87 | 884.21 | 4.87 | 2605.56 | 4.43 | 3064.29 |
| 2017 (3) | 25 | 8.7 | 0.56 | -46.67 | 0.15 | -44.44 | 3.58 | 26.5 | 35.21 | -16.19 | 5.20 | -51.81 | 4.29 | -50.52 | 0.19 | -38.71 | 0.18 | -35.71 | 0.14 | -44.0 |
| 2016 (2) | 23 | 4.55 | 1.05 | -30.0 | 0.27 | 58.82 | 2.83 | 18.91 | 42.01 | -1.06 | 10.79 | 35.38 | 8.67 | -38.77 | 0.31 | 63.16 | 0.28 | -20.0 | 0.25 | -26.47 |
| 2015 (1) | 22 | 0.0 | 1.50 | 94.81 | 0.17 | -19.05 | 2.38 | 9.17 | 42.46 | 0 | 7.97 | 0 | 14.16 | 0 | 0.19 | -26.92 | 0.35 | 75.0 | 0.34 | 100.0 |
免責聲明
本網站所有資料僅供參考，如使用者依本資料交易發生交易損失需自行負責，本網站對資料內容錯誤﹑更新延誤不負任何責任。